ODDB.org: Open Drug Database | Drugs

Imraldi 40 mg/0.8 ml, Injektionslösung im Fertigpen -

Swissmedic Key	67582001	Registration Holder	Samsung Bioepis CH GmbH
Name	Imraldi 40 mg/0.8 ml, Injektionslösung im Fertigpen	Date of registration	03.04.2020
		Introduction of Sequence	03.04.2020
ATC-Classification	Adalimumab (L04AB04)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.15.	Show package size
Index Therapeuticus (Swissmedic)	07.15.	Description
Swissmedic categorie.	B
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	371.10	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	419.95
Feedback	FB
GTIN	7680675820016	Medication Code	Biotechnologika
Pharmacode	7771899	Disponibility

Composition

adalimumabum 40 mg, natrii citras dihydricus, acidum citricum monohydricum, histidinum, histidini hydrochloridum monohydricum, sorbitolum 20 mg, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.375 mg.

Packungsbestandteile

Galenic Form

Injektionslösung im Fertigpen

Excipiens

Active Agent	Dose
Adalimumabum	40mg / 0.8ml

BAG: Active Agent	Dose
Adalimumabum	40 mg

Inactive agents	Dose
Acidum Citricum Monohydricum
Histidini Hydrochloridum Monohydricum
Histidinum
Natrii Citras Dihydricus
Polysorbatum 20
Sorbitolum	20mg / 0.8ml

Source

Data was imported : 07.01.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH